STRATEC Biomedical AG 

20.01.2014 18:05

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

Allianz SE, Munich, Germany, notified us on January 15, 2014 pursuant to section 25 (1) of the German Securities Trading Act (WpHG) as follows:
'We hereby give notice pursuant to section 25 (1) of the German Securities Trading Act (WpHG) that our voting rights in STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld, Germany, fell below the threshold of 5% on January 10, 2014 and amounted to 0% of all voting rights in the company, corresponding to 0 of the total 11,770,245 voting rights.
Due to (financial/other) instruments, the share of voting rights pursuant to section 25 of the German Securities Trading Act (WpHG) amounted to 0%, corresponding to 0 of the total 11,770,245 voting rights.
The share of voting rights pursuant to sections 21 and 22 of the German Securities Trading Act (WpHG) amounted to 5.18%, corresponding to 610,001 of the total 11,770,245 voting rights.'



20.01.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  

---